Capítulo 15 – Inmunosupresión en el trasplante hepático

L. Makowka, A. Stieber, S. Todo, A. G. Tzakis, T. E. Starzl, Baburao Koneru, S. Iwatsuki, B. Husberg, C. O. Esquivel, R. D. Gordon, J. W. Marsh, G. Klintmalm, Experience in 1,000 liver transplants under cyclosporine-steroid therapy: A survival report Transplantation proceedings. ,vol. 20, pp. 498- 504 ,(1988)

J.R. Lake, K.M. David, B.J. Steffen, A.H. Chu, R.D. Gordon, R.H. Wiesner, Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. American Journal of Transplantation. ,vol. 5, pp. 2961- 2967 ,(2005) , 10.1111/J.1600-6143.2005.01117.X

V. C. McAlister, E. Haddad, E. Renouf, R. A. Malthaner, M. S. Kjaer, L. L. Gluud, Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta‐Analysis American Journal of Transplantation. ,vol. 6, pp. 1578- 1585 ,(2006) , 10.1111/J.1600-6143.2006.01360.X

R. H. Wiesner, B. J. Steffen, K. M. David, A. H. Chu, R. D. Gordon, J. R. Lake, Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients. American Journal of Transplantation. ,vol. 6, pp. 1609- 1616 ,(2006) , 10.1111/J.1600-6143.2006.01382.X

Bryan D. Myers, Richard Sibley, Lynne Newton, Stephen J. Tomlanovich, Christopher Boshkos, Edward Stinson, John A. Luetscher, Darlene J. Whitney, David Krasny, Norman S. Coplon, Mark G. Perlroth, The long-term course of cyclosporine-associated chronic nephropathy Kidney International. ,vol. 33, pp. 590- 600 ,(1988) , 10.1038/KI.1988.38

Marina Berenguer, Ana Royuela, Javier Zamora, Immunosuppression With Calcineurin Inhibitors With Respect to the Outcome of HCV Recurrence After Liver Transplantation: Results of a Meta-analysis Liver Transplantation. ,vol. 13, pp. 21- 29 ,(2007) , 10.1002/LT.21035

Luca S. Belli, Alberto B. Alberti, Marcello Vangeli, Aldo Airoldi, Giovambattista Pinzello, Tapering off steroids three months after liver transplantation is not detrimental for hepatitis C virus disease recurrence. Liver Transplantation. ,vol. 9, pp. 201- 202 ,(2003) , 10.1053/JLTS.2002.50033

Jose Maria Moreno Planas, Valentin Cuervas-Mons Martinez, Eduardo Rubio Gonzalez, Amparo Gomez Cruz, Javier Lopez-Monclus, Victor Sanchez-Turrion, Jose Luis Lucena Poza, Manuel Jimenez Garrido, Isabel Millan, Mycophenolate mofetil can be used as monotherapy late after liver transplantation. American Journal of Transplantation. ,vol. 4, pp. 1650- 1655 ,(2004) , 10.1111/J.1600-6143.2004.00556.X

Franco Filipponi, Francesco Callea, Mauro Salizzoni, Gian Luca Grazi, Luigi Rainero Fassati, Massimo Rossi, Andrea Risaliti, Patrizia Burra, Salvatore Agnes, Luciano De Carlis, Umberto Valente, Roberto Ferrara, Roberto Pisati, Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine Transplantation. ,vol. 78, pp. 1488- 1495 ,(2004) , 10.1097/01.TP.0000140881.07208.4E

Russell H. Wiesner, Jolene S. Shorr, Bettina J. Steffen, Alice H. Chu, Robert D. Gordon, John R. Lake, Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transplantation. ,vol. 11, pp. 750- 759 ,(2005) , 10.1002/LT.20453